Do Dynamic Urinary Leukocyte and Nitrite Changes Improve Risk Prediction for Infectious Complications Following PCNL?
NCT ID: NCT07238673
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
346 participants
OBSERVATIONAL
2021-03-01
2025-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective To evaluate the association between temporal changes in preoperative urinary white blood cells (WBC) and nitrite (NIT) and the risk of postoperative fever and urosepsis in patients undergoing PCNL.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is it Necessary for Patients With a Positive Urine Culture to Achieve a Negative Result After Antimicrobial Treatment Before Undergoing Percutaneous Nephrolithotomy?
NCT06210425
The Effect of Preoperative Culture Timing on Postoperative Outcomes of Retrograde Intrarenal Surgery
NCT06723327
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
NCT04669886
Resistance Characteristics and Development of Diagnostic Model for Postoperative UTI in Patients With Kidney Stones
NCT06946667
Characteristics of Renal Blood Flow in AKI Patients in ICU and Its Clinical Significance
NCT06090773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Urolithiasis represents one of the most frequently encountered disorders in urological practice, and its global incidence has been increasing steadily in recent years, making it a significant public health concern that not only impairs patients' quality of life while creating considerable financial strain and increasing demands on healthcare systems . Percutaneous nephrolithotomy (PCNL) is now the primary therapeutic option recommended by international guidelines for medium-to-large and complex renal calculi, owing to its proven efficacy, minimal invasiveness, and rapid recovery . However, unavoidable factors during this procedure-such as high-pressure irrigation, migration of stone fragments, and injury to the renal pelvic mucosa-may facilitate the translocation of bacteria and endotoxins into the bloodstream, thereby triggering postoperative infectious complications, particularly fever and urosepsis. These complications can significantly impair postoperative recovery and prognosis and may even pose life-threatening risks .
Currently, preoperative urine culture is routinely used to assess a patient's infectious status and to guide perioperative antibiotic administration. However, this method has certain limitations, including a prolonged turnaround time (48-72 hours), susceptibility to sampling contamination, and the intermittent nature of bacteriuria, which restrict its utility in rapid clinical decision-making. In contrast, urinalysis is an economical, convenient, and repeatable test that is widely applied in preoperative evaluation. Among its parameters, urinary white blood cells (WBC) detected by microscopy and urinary nitrite (NIT) can serve as indirect indicators of urinary tract infection. Previous studies have demonstrated that preoperative WBC or NIT positivity is significantly associated with postoperative infectious complications following PCNL. A meta-analysis involving 6,113 patients reported that preoperative WBC positivity (OR ≈ 3.86) and NIT positivity (OR ≈ 7.81) were both independent risk factors. However, most of these studies were based on a single measurement and lacked a systematic evaluation of preoperative dynamic trends.
On this basis, the present study proposes a new clinical question: Can the dynamic changes in preoperative urinalysis WBC and NIT serve as effective predictors of postoperative infection risk in patients undergoing PCNL? To address this, we prospectively collected urinalysis data at admission and immediately before surgery, stratified patients according to dynamic change patterns, and analyzed the associations with postoperative fever and urosepsis, with the aim of providing a reference for clinical risk stratification and individualized anti-infective strategies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Renal stone diameter ≥ 2 cm, or complex renal stones, or failure of extracorporeal shock-wave lithotripsy (ESWL)
* American Society of Anesthesiologists (ASA) physical status class I or II
* Positive outpatient midstream urine culture
Exclusion Criteria
* Fever on admission
* Concomitant renal tumor; Active, symptomatic urinary tract infection
* Use of antibiotics for other reasons within 1 month prior to admission
* Preoperative indwelling ureteral stent, nephrostomy tube, or double-J stent
* Uncontrolled diabetes mellitus
* Chronic kidney disease stage IIIa or higher (eGFR \< 60 mL/min/1.73 m²)
* Ongoing immunosuppressive therapy; Simultaneous bilateral renal stone surgery
* Severe comorbidities (e.g., respiratory or circulatory failure) that preclude anesthesia or surgery
* Pregnancy or lactation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital of Guangzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Junhao Zheng
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, GuangGong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GYFYZJH1015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.